Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting - Associated Press

Submitted by Anonymous (not verified) on Tue, 05/21/2019 - 11:38

Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting  Associated PressPress release *content* from Globe Newswire. The AP news staff was not involved in its creation.